Fidelity's increased passive stake to 6.1% aligns with the strong FILSPARI revenue trajectory reported on November 2. Monitor for any future conversion to an active 13D filing, which would signal a change in investment approach.
TVTX drugs
TVTX drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 5 $48.87entry
- T+1 · 11d ago +1.49%α +1.18% · $49.60
- T+5 · 5d ago +5.50%α +2.21% · $51.56
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
FMR LLC (Fidelity) filed an amended Schedule 13G reporting a 6.1% passive stake in Travere Therapeutics as of September 30, 2026, up from 5.0% in the prior filing. The increase follows strong Q3 FILSPARI sales of $200.2M (up 120% YoY) reported on November 2, 2026. This is a routine passive stake update with no change in investment intent.
Key Financial Metrics
Key Facts
- FMR LLC reported beneficial ownership of 5,707,883 shares of Travere Therapeutics common stock as of September 30, 2026
- The stake represents 6.1% of shares outstanding
- This is an amendment to a Schedule 13G, indicating passive investment intent
- The prior FMR LLC filing (August 6, 2026) reported a 5.0% stake
- The filing was made on November 5, 2026, three days after Travere reported Q3 2026 earnings
Financial Impact
FMR LLC increased its stake from 5.0% to 6.1% of Travere Therapeutics, representing an additional ~1.1% of shares outstanding
Risk Factors
- FMR LLC remains a passive filer under Rule 13d-1(b); no activist intent is indicated
- The filing is retrospective as of September 30, 2026; current ownership may differ
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000315066-26-002862 |
| Document: 0000315066-26-002862-index-headers.html | 0000315066-26-002862 |
| Document: 0000315066-26-002862-index.html | 0000315066-26-002862 |
| Document: 0000315066-26-002862.txt | 0000315066-26-002862 |
Track record
21 reports on TVTX
8 of 10 bullish or bearish reports moved the stock their way by T+5. Best: +56.24% at T+60 after the Jun 2, 2026 report. 10 of 10 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $50.30 Now $49.70 −1.19% settles Nov 23
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Viewing Entry $48.87 to $51.56 Now $49.70 +1.70% ▲ +5.50% +2.21% vs SPY
- Nov 3, 202613d ago Institutional Cluster Bullish 4/10 Entry $49.41 to $51.99 Now $49.70 +0.59% ▲ +5.22% +5.81% vs SPY
- Nov 2, 202614d ago 8-K Bullish 6/10 Entry $49.41 to $51.99 Now $49.70 +0.59% ▲ +5.22% +5.81% vs SPY
- Sep 17, 20268w ago Insider Cluster Bearish 4/10 Entry $62.76 to $59.44 Now $49.70 +20.81% ▲ +5.29% +6.56% vs SPY
- Jul 9, 202618w ago 8-K Neutral 2/10 Entry $56.59 to $55.28 Now $49.70 −12.18% ▼ −2.31% −1.75% vs SPY
- Jun 16, 202621w ago Insider Cluster Neutral 2/10 Entry $54.14 to $57.69 Now $49.70 −8.20% ▲ +6.56% +7.60% vs SPY
- Jun 16, 202621w ago 8-K Neutral 2/10 Entry $54.14 to $57.69 Now $49.70 −8.20% ▲ +6.56% +7.60% vs SPY
- Jun 12, 202622w ago 144 Neutral 2/10 Entry $52.04 to $55.15 Now $49.70 −4.50% ▲ +5.98% +5.30% vs SPY
- Jun 2, 202623w ago 8-K Bullish 6/10 Entry $42.96 to $48.57 Now $49.70 +15.69% ▲ +13.06% +16.02% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers